NOVONESIS A/S NAM. B DK 2
NOVONESIS A/S NAM. B DK 2/ DK0060336014 /
NZM2
|
2024-04-16 9:30:57 AM
|
Chg.
-0.16
|
Volume |
Bid10:00:01 AM |
Ask10:00:01 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
50.80EUR
|
-0.31%
|
0
Turnover: 0.00 |
51.16Bid Size: 710 |
51.42Ask Size: 710 |
14.31 bill.EUR |
- |
- |
Business description
Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
Management board & Supervisory board
| CEO |
| Ester Baiget |
| Management board |
| Rainer Lehmann, Amy Byrick, Anders Lund, Claus Crone Fuglsang, Graziela Chaluppe dos Santos Malucelli, Morten Enggaard Rasmussen, Tina Sejersgård Fanø |
| Supervisory board |
| Cees de Jong, Andreas Hentze Knudsen, Anne Breum, Cees de Jong, Heine Dalsgaard, Jens Øbro, Kasim Kutay, Kim Stratton, Mathias Uhlén, Preben Nielsen, Sharon James |
Company data
| Name: |
Novozymes A.S |
| Address: |
Krogshoejvej 36,DK-2880 Bagsvaerd |
| Phone: |
+45-44-460000 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.novozymes.com/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
74.50% |
| IPO date: |
2000-11-20 |
Company calendar
|
CW 18 | 2024-04-30
General Shareholder Meeting
|
|
CW 18 | 2024-05-03
Interim Report 1st Quarter/3 Months
|
|
CW 35 | 2024-08-28
Interim Report 2nd Quarter/6 Months
|
|
CW 45 | 2024-11-07
Interim Report 3rd Quarter/9 Months
|
|
CW 9 | 2025-02-26
4th Quarter/Annual Report
|
